Company Filing History:
Years Active: 2022-2025
Title: Innovations by Stephen D. Preite: Pioneering Advances in Radiochemistry
Introduction
Stephen D. Preite, an accomplished inventor based in Charlotte, NC, has significantly contributed to the field of radiochemistry through his innovative patents. With two patents to his name, Preite has made remarkable strides in developing systems and methods for evaluating radiopurity in medical applications.
Latest Patents
Preite's latest inventions focus on enhancing the efficiency of Technetium-99m (Tc-99m) generators. His first patent, titled "System and method for evaluating elution efficiency and radiopurity of Tc-99m generators," presents a novel system equipped with an elution detector made of shielding metal. This innovative system includes a flow path template designed for the efficient analysis of an eluate produced from a generator. It allows for simultaneous monitoring of both the generator and the eluate exiting it, ensuring high radiochemical purity in medical diagnostics.
His second patent, "Metal-molybdate and method for making the same," outlines a method for producing metal-molybdate material. This process involves reacting a metal molybdenum material with a first acid to yield a Mo composition, which is then combined with a metal source to create a metal-Mo composition. The method includes pH adjustment techniques to precipitate metal-Mo particulates, potentially streamlining the manufacturing process in radiochemical applications.
Career Highlights
Stephen D. Preite is affiliated with BWXT Isotope Technology Group, Inc., a company dedicated to advancing nuclear technology and isotope production. His work at BWXT focuses on integrating innovative solutions to enhance the efficiency and safety of radiochemical applications. Preite's demonstrated expertise has made him a notable figure in the field, where he continues to push the boundaries of existing technology.
Collaborations
Throughout his career, Preite has collaborated with notable colleagues, including Earl Brian Barger and Christopher Sean Fewox. These partnerships exemplify a commitment to advancing technologies that support medical imaging and diagnostic processes, underscoring the collective effort to innovate within the industry.
Conclusion
Stephen D. Preite’s contributions to patenting innovative systems and methods in radiochemistry highlight his significant role as an inventor. His notable patents not only advance technological capabilities but also enhance safety and effectiveness in medical applications. As he continues his work with BWXT Isotope Technology Group, his innovations will likely have a lasting impact on the field of radiochemistry and beyond.